They develop a non-invasive test in the United States to detect preeclampsia early

Preeclampsia is a complication of pregnancy, which is characterized by high blood pressure and protein in the urine, and can have serious consequences for both the mother and the baby. In most cases this complication, which usually develops in the 20th week of pregnancy, is detected until the last quarter.

Control appointments during pregnancy are important to detect possible complications, but initially the symptoms of preeclampsia could be confused with other typical pregnancy. Thus, a non-invasive test to detect preeclampsia is being developed in the United States early.

Researchers at the Wexler Medical Center at the University of Ohio are responsible for this new test to detect preeclampsia, which could help prevent serious consequences during pregnancy, childbirth or postpartum caused by this complication.

In Babies and more What is preeclampsia: risk factors, symptoms, prevention and treatment

This new way of detecting it is still in the testing stage and has not yet been approved by the US Food and Drug Administration (FDA), but it is expected to be available soon. to be able to detect and treat this condition early during pregnancy.

The proof, that It is designed to identify preeclampsia accurately in just three minutes, would work similar to a urine test: a red ink would react or activate if protein was found in the urine of pregnant women who have preeclampsia.

As we mentioned, it is still in the test stage, but it is expected that after completing it, the test will be approved by the FDA so that it can begin to be used in the coming years, helping to detect preeclampsia early.

Video: 2018 Demystifying Medicine: Prenatal Genomics and Fetal Gene Therapy (April 2024).